Llwytho...
Vedolizumab in the treatment of inflammatory bowel diseases: whom and how?
The article is devoted to the use of vedolizumab, an α4β7 integrin antagonist, in the treatment of inflammatory bowel diseases (ulcerative colitis and Crohn’s disease). It presents the results of clinical trials of the drug and the experience of using vedolizumab in actual clinical practice. The lat...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Russo |
| Cyhoeddwyd: |
Remedium Group LLC
2018-10-01
|
| Cyfres: | Медицинский совет |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.med-sovet.pro/jour/article/view/2650 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|